BATON ROUGE, La., March 15, 2018 -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, received an average rating of 4.22 Stars out of a possible 5 for Quality of Patient Care across its home health care centers from the Centers for Medicare & Medicaid Services (CMS) January Star Ratings release.
That figure is nearly 30 percent above the industry average and represents an almost 8 percent increase from Amedisys’ Quality of Patient Care rating from a year ago. Also, 88 percent of Amedisys’ home health care centers achieved a rating of 4 Stars or better.
“In 2015, we committed Amedisys to the cause of clinical excellence, and this impressive result is a testament to our clinical team’s determination to deliver the highest quality of care,” stated President and Chief Executive Officer Paul Kusserow. “No metric better demonstrates our determination to deliver outstanding clinical results.”
Amedisys had 19 providers, including 30 care centers, that achieved a 5-Star rating. According to the April 2018 Preview, that figure will likely increase to 29 providers, representing 54 care centers, with 56 percent of home health agencies achieving 4.5 Stars or more.
“When it comes to delivering quality patient care, our care centers rank among the top in the nation,” stated Chief Clinical Officer Susan Sender. “We’re committed to clinical distinction and will continue to invest in our clinicians to achieve even better outcomes for our patients.”
According to CMS, its Home Health Compare website is designed to be a key tool for consumers to choose a home health provider – an “easy-to-access, convenient source of authoritative information on provider quality.” In 2015, CMS added to its reporting system a one-to-five Star Rating to “summarize” 24 measures of provider performance such as “timely initiation of care” and “improvement in ambulation.”
About Amedisys:
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. We partner with 3,000 hospitals and 59,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 17,500 employees, in 426 care centers in 35 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 369,000 patients and clients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact:
Kendra Kimmons
Vice President of Marketing & Communications
225-299-3708
[email protected]


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Anta Sports Expands Global Footprint With Strategic Puma Stake
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 



